Gout Prevalent in German CKD Cohort The 10-year prevalence of colonoscopy-documented colorectal cancer was 0.8% among gout patients vs 3.7% among osteoarthritis patients. Patients with gout have a ...
There are a lot of research eyes on the development of Polo-like kinase 1 (PLK1) inhibitors for cancer treatment right now, with several drugs currently in clinical trials and at least one in ...
Chronic tophaceous gout (CTG) is an independent risk factor for colorectal cancer (CRC), according to study results presented at Digestive Disease Week (DDW), held from May 6 to 9, 2023 in Chicago, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback